CVM
AMEX
$1.48
Cel-Sci Corp (CVM)
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
Sector:
Healthcare
Industry:
Biotechnology
Target: $25 (+1589.19%)
Market Cap
$10M
Beta (5Y)
0.82
Price Chart
Valuation
Market Cap$10M
Forward P/E23.04
PEG1.12
P/S92.88
P/B1.29
Profitability
Gross Profit (TTM)-$15M
EBITDA-$21M
EPS-$4.82
Growth & Risk
EPS 5Y CAGR-28.56%
FCF 5Y CAGR-0.15%
Beta (5Y)0.82
Sharpe Ratio0.33